1,504
Views
16
CrossRef citations to date
0
Altmetric
Original Article

A model for managing patient booking in a radiotherapy department with differentiated waiting times

&
Pages 251-258 | Received 20 May 2008, Published online: 08 Jul 2009

References

  • Lim KSH, Vinod SK, Bull C, O'Brien P, Kenny L. Prioritization of radiotherapy in Australia and New Zealand. Australas Radiol 2005; 49: 485–8
  • Ash D, Barrett A, Hinks A, Squire C. Re-audit of radiotherapy waiting times 2003. Clin Oncol 2004; 16: 387–94
  • D'Souza DPD, Martin DK, Purdy L, Bezjak A, Singer PA. BMC Health Ser Res 2001; 1: 3
  • Primdahl H, Nielsen AL, Larsen S, Andersen E, Ipsen M, Lajer C, Vestermark LW, et al. Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: A Danish nationwide survey from DAHANCA. Acta Oncol 2006; 45: 156–61
  • Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol 2007; 84: 5–10
  • Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcome: A systematic review of the literature. Radiother Oncol 2008; 87: 3–16
  • Thomas SJ. Capacity and demand models for radiotherapy treatment machines. Clin Oncol 2003; 15: 353–8
  • DSI Institute of healthcare on behalf of The National Board of Health A model based analysis of future capacity requirements in radiotherapy [Modelbaseret analyse af det fremtidige kapacitetsbehov på stråleterapiområdet]. 2005. http://www.dsi.dk/frz_publikationer.htm.
  • Delaney GP, Gebski V, Lunn AD, Lunn M, Rus M, Manderson C, Langlands AO, et al. Basic treatment equivalent (BTE): A new measure of linear accelerator workload. Clin Oncol 1997; 9: 234–9
  • Martin JM, Duchesne Ryan G. Clinical priorisitation for curative radiotherapy: A local waiting list initiative. Clin Oncol 2004; 16: 299–306
  • Munro AJ, Potter S. Waiting times for radiotherapy treatment: Not all that mysterious and certainly preventable. Clin Oncol 1994; 6: 314–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.